Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study

Transfusion

Volumn 57, Issue 3, 2017, Pages 525-532

  Delaney, Meghan ^a   Wikman, Agneta ^b   van de Watering, Leo ^c   Schonewille, Henk ^c   Verdoes, Jennie P ^c   Emery, Stephen P ^d   Murphy, Michael F ^e   Staves, Julie ^f   Flach, Susanne ^f   Arnold, Donald M ^g   Kaufman, Richard M ^h   Ziman, Alyssa ⁱ   Harm, Sarah K ^j   Fung, Mark ^j   Eppes, Catherine S ^k   Dunbar, Nancy M ^l   Buser, Andreas ^m   Meyer, Erin ⁿ   Savoia, Helen ^o   Abeysinghe, Padmakumari ^o   Heddle, Nancy ^g   Tinmouth, Alan ^p   Traore, Aicha N ^g   Yazer, Mark H ^d   more..

^a UNIVERSITY OF WASHINGTON   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

^f OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^g MCMASTER UNIVERSITY   (Canada)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j FLETCHER ALLEN HEALTH CARE   (United States)

^k BAYLOR COLLEGE OF MEDICINE   (United States)

^l DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^m Blood Transfusion Center   (Switzerland)

ⁿ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o ROYAL CHILDREN'S HOSPITAL   (Australia)

^p OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BLOOD GROUP ANTIGEN; ALLOANTIBODY;

ADULT; ALLOIMMUNIZATION; ANEMIA; ARTICLE; BLOOD GROUP TYPING; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; FEMALE; HUMAN; INJURY; INTRAUTERINE BLOOD TRANSFUSION; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASM; MIDDLE AGED; NEWBORN; NEWBORN HEMOLYTIC DISEASE; OBSTETRIC HEMORRHAGE; PREGNANCY OUTCOME; PROGENY; RETROSPECTIVE STUDY; TREATMENT INDICATION; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; ERYTHROBLASTOSIS, FETAL; FETOMATERNAL TRANSFUSION; MULTICENTER STUDY; PREGNANCY;

ADULT; BLOOD GROUP ANTIGENS; BLOOD GROUPING AND CROSSMATCHING; ERYTHROBLASTOSIS, FETAL; FEMALE; FETOMATERNAL TRANSFUSION; HUMANS; ISOANTIBODIES; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 85012965242     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13977     Document Type: Article

References (15)

1. Koelewijn JM, Vrijkotte TG, de Haas M, et al. Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy. BJOG 2009;116:655-64.
2. Higgins JM, Sloan SR. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood 2008;112:2546-53.
3. Smits-Wintjens VE, Rath ME, van Zwet EW, et al. Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease. Neonatology 2013;103:141-7.
4. Lindenburg IT, Smits-Wintjens VE, van Klink JM, et al. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study. Am J Obstet Gynecol 2012;206:141.e1-8.
5. Castro O, Sandler SG, Houston-Yu P, et al. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002;42:684-90.
6. Shirey RS, Boyd JS, Parwani AV, et al. Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management. Transfusion 2002;42:1435-41.
7. Rath ME, Smits-Wintjens VE, Lindenburg IT, et al. Postnatal outcome in neonates with severe Rhesus c compared to Rhesus D hemolytic disease. Transfusion 2013;53:1580-5.
8. Lindenburg IT, van Kamp IL, van Zwet EW, et al. Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation. BJOG 2013;120:847-52.
9. Koelewijn JM, Vrijkotte TG, van der Schoot CE, et al. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion 2008;48:941-52.
10. Dajak S, Culic S, Stefanovic V, et al. Relationship between previous maternal transfusions and haemolytic disease of the foetus and newborn mediated by non-RhD antibodies. Blood Transfus 2013;11:528-32.
11. Schonewille H, Klumper FJ, van de Watering LM, et al. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus. Am J Obstet Gynecol 2007;196:143.e1-6.
12. Harm SK, Yazer MH, Monis GF, et al. A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease. Am J Clin Pathol 2014;141:256-61.
13. Nance ST. Operational issues for implementation of donor genotyping for red blood cell antigens. Transfusion 2007;47:69S-72S.
14. Flegel WA, Gottschall JL, Denomme GA. Implementing mass-scale red cell genotyping at a blood center. Transfusion 2015;55:2610-5; quiz 2609.
15. Veldhuisen B, van der Schoot CE, de Haas M. Blood group genotyping: from patient to high-throughput donor screening. Vox Sang 2009;97:198-206.